Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Future Oncology (London, England)|July 6, 2022
Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic contextAntonio González-Martín, Ursula A Matulonis, Jacob Korach, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Anti-mesothelin antibodies and circulating mesothelin relate to the clinical state in ovarian cancer patientsIngegerd Hellstrom, Eitan Friedman, Thorsten Verch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 24, 2023
Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervixShira Peleg Hasson, Shira Felder, Limor Helpman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center studyLimor Helpman, Tamar Perri, Natalie Lavee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 18, 2016
Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B StudyAmit M Oza, Frédéric Selle, Irina Davidenko, et al.
Cancer|November 30, 2018
Uterine cancer in Jewish Israeli BRCA1/2 mutation carriersYael Laitman, Rachel Michaelson-Cohen, Einat Levi, et al.
Gynecologic Oncology|November 13, 2024
Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancerKatherine Elizabeth Francis, Sandy Simon, Val Gebski, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2020
Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group surveyStefano Greggi, Francesca Falcone, Cono Scaffa, et al.
Neoplasia (New York, N.Y.)|March 4, 2016
Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous CarcinogenesisStav Sapoznik, Keren Bahar-Shany, Hadar Brand, et al.
The Lancet. Oncology|July 30, 2017
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trialEric Pujade-Lauraine, Jonathan A Ledermann, Frédéric Selle, et al.
Pageof 7